Search Results - "GURTOVAYA, Oksana"

Phase II, randomised, double-blind, multicentre study evaluating the safety and efficacy of filgotinib and lanraplenib in patients with lupus membranous nephropathy by Baker, Matthew, Chaichian, Yashaar, Genovese, Mark, Derebail, Vimal, Rao, Panduranga, Chatham, Winn, Bubb, Michael, Lim, Sam, Hajian, Hooman, Gurtovaya, Oksana, Patel, Uptal, Tumlin, James

“…ObjectivesPatients with lupus membranous nephropathy (LMN) are at risk for prolonged proteinuria and progressive chronic kidney disease. There are no proven…”
Get full text

Modulation of the voltage sensor of L-type Ca2+ channels by intracellular Ca2 by Isaev, Dmytro, Solt, Karisa, Gurtovaya, Oksana, Reeves, John P, Shirokov, Roman

“…Both intracellular calcium and transmembrane voltage cause inactivation, or spontaneous closure, of L-type (CaV1.2) calcium channels. Here we show that…”
Get full text

Filgotinib or lanraplenib in moderate to severe cutaneous lupus erythematosus: a phase 2, randomized, double-blind, placebo-controlled study by Werth, Victoria P, Fleischmann, Roy, Robern, Michael, Touma, Zahi, Tiamiyu, Iyabode, Gurtovaya, Oksana, Pechonkina, Alena, Mozaffarian, Afsaneh, Downie, Bryan, Matzkies, Franziska, Wallace, Daniel

“…Abstract Objectives To explore the safety and efficacy of filgotinib (FIL), a Janus kinase 1 inhibitor, and lanraplenib (LANRA), a spleen kinase inhibitor, in…”
Get full text

Safety and efficacy of filgotinib, lanraplenib and tirabrutinib in Sjögren's syndrome: a randomized, phase 2, double-blind, placebo-controlled study by Price, Elizabeth, Bombardieri, Michele, Kivitz, Alan, Matzkies, Franziska, Gurtovaya, Oksana, Pechonkina, Alena, Jiang, Wendy, Downie, Bryan, Mathur, Anubhav, Mozaffarian, Afsaneh, Mozaffarian, Neelufar, Gottenberg, J Eric

“…The aim of this study was to characterize the safety and efficacy of filgotinib, lanraplenib and tirabrutinib in patients with active SS. This multicentre,…”
Get full text

Pseudomonas aeruginosa Susceptibility Patterns and Associated Clinical Outcomes in People with Cystic Fibrosis following Approval of Aztreonam Lysine for Inhalation by Keating, Claire L, Zuckerman, Jonathan B, Singh, Pradeep K, McKevitt, Matthew, Gurtovaya, Oksana, Bresnik, Mark, Marshall, Bruce C, Saiman, Lisa

“…The approval of aztreonam lysine for inhalation solution (AZLI) raised concerns that additional antibiotic exposure would potentially affect the susceptibility…”
Get full text

ALPINE2: Efficacy and safety of 14-day vs 28-day inhaled aztreonam for Pa eradication in children with cystic fibrosis by Gilchrist, Francis J., Bui, Stephanie, Gartner, Silvia, McColley, Susanna A., Tiddens, Harm, Ruiz, Gary, Stehling, Florian, Alani, Muhsen, Gurtovaya, Oksana, Bresnik, Mark, Watkins, Timothy R., Frankovic, Biliana, Skov, Marianne

“…•28-day AZLI is indicated to treat P. aeruginosa (Pa) infection in people with CF.•28-day nebulized treatment eradication protocols can be burdensome for…”
Get full text

Efficacy and Safety of Adjunctive Oral Ziprasidone for Acute Treatment of Depression in Patients With Bipolar I Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial by SACHS, Gary S, ICE, Kathleen S, CHAPPELL, Phillip B, SCHWARTZ, Jeffrey H, GURTOVAYA, Oksana, VANDERBURG, Douglas G, KASUBA, Bryce

“…To assess efficacy and safety of adjunctive ziprasidone in subjects with bipolar depression treated with lithium, lamotrigine, or valproate. 298 adult…”
Get full text

No increased bleeding events in patients with relapsed chronic lymphocytic leukemia and indolent non-Hodgkin lymphoma treated with idelalisib by Barrientos, Jacqueline C., Hillmen, Peter, Salles, Gilles, Sharman, Jeff, Stilgenbauer, Stephan, Gurtovaya, Oksana, Xing, Guan, Ruzicka, Bianca, Bhargava, Pankaj, Ghia, Paolo, Pagel, John M.

“…The advent of novel B-cell receptor pathway targeting agents like ibrutinib dramatically changed management of B-cell malignancies. However, with concomitant…”
Get full text

Outcomes of anticoagulant (AC) or antiplatelet (AP) use in patients (pts) with chronic lymphocytic leukemia (CLL) or indolent non-Hodgkin’s lymphoma (iNHL) in idelalisib (IDELA) trials by Barrientos, Jacqueline Claudia, Ghia, Paolo, Pagel, John, Salles, Gilles A., Sharman, Jeff Porter, Stilgenbauer, Stephan, Gurtovaya, Oksana, Kim, Yeonhee, Philip, Betsy, Zelenetz, Andrew David

“…Abstract only…”
Get full text

Modulation of the voltage sensor of L-type Ca2+ channels by intracellular Ca2 by Isaev, Dmytro, Solt, Karisa, Gurtovaya, Oksana, Reeves, John P, Shirokov, Roman

“…Both intracellular calcium and transmembrane voltage cause inactivation, or spontaneous closure, of L-type (CaV1.2) calcium channels. Here we show that…”
Get full text